Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine
Clinical trial NCT03391193 · COMPLETED
Trial details
- NCT number
- NCT03391193
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2018-03-28
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.